{"studyId":"pancreas_ctdna_msk_2025","cancerTypeId":"paad","name":"Pancreatic Cancer cfDNA (MSK, J Natl Cancer Inst 2025)","description":"Genomic profiling by ctDNA is feasible in patients with PDAC and is informative in specific groups such as those with untreated metastatic disease, higher disease burden and liver metastases.","publicStudy":true,"pmid":"40511613","citation":"Fergus et al. J Natl Cancer Inst 2025","groups":"","status":1,"importDate":"2026-01-28 13:40:32","allSampleCount":412,"sequencedSampleCount":412,"cnaSampleCount":412,"mrnaRnaSeqSampleCount":0,"mrnaRnaSeqV2SampleCount":0,"mrnaMicroarraySampleCount":0,"miRnaSampleCount":0,"methylationHm27SampleCount":0,"rppaSampleCount":0,"massSpectrometrySampleCount":0,"completeSampleCount":0,"referenceGenome":"hg19","treatmentCount":0,"structuralVariantCount":5,"cancerType":{"id":"paad","name":"Pancreatic Adenocarcinoma","dedicatedColor":"Purple","shortName":"PAAD","parent":"pancreas"},"readPermission":true,"resourceCounts":[]}